Zurich identifies Sixfold, alongside Nearmap and Convr, as an AI vendor supporting its underwriters in a Connecticut filing for its Property Portfolio Protection product.
The disclosure does not specify which tasks each vendor performs or establish that Sixfold is used specifically for the life sciences coverage addressed in the submission.
Submitted July 30, 2026, the filing revises Zurich’s optional Life Sciences Transitional Business – Continuing Expense endorsement. The revised language explicitly ties coverage to a suspension of research and development operations caused by covered physical loss or damage and removes a penalty for underreporting continuing expenses.
Zurich requested an October 15, 2026 effective date for new and renewal business. The supplied filing snapshot, generated August 12, lists the submission as assigned and contains no approval disposition.

